Write in a clean editor, then format for Contemporary Clinical Trials Communications in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Contemporary Clinical Trials Communications is a peer-reviewed journal published by Elsevier, covering Ethics in Clinical Research, Statistical Methods in Clinical Trials, Health Systems, Economic Evaluations, Quality of Life.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Contemporary Clinical Trials Communications 12 (2023) 45–58.
Formats any DOI in Contemporary Clinical Trials Communications style. No sign-up. |
| Publishes research in | Ethics in Clinical Research Statistical Methods in Clinical Trials Health Systems, Economic Evaluations, Quality of Life Meta-analysis and systematic reviews Health Policy Implementation Science |
| ISSN | 2451-8654 |
| Citation impact (2-yr) | 1.64 |
| h-index | 41 |
| i10-index | 469 |
| Total citations | 15,397 |
| Article processing charge | $1,890 |
| Open access | Yes |
| Top institutions publishing here | Harvard University |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Clinical trials are time consuming, expensive, and often burdensome on patients. Clinical trials can fail for many reasons. This survey reviews many of these reasons and offers insights on opportunities for improving the likelihood of creating and executing successful clinical trials. Literature from the past 30 years was reviewed for relevant data. Common patterns in…
BACKGROUND: Regarding the analysis of RCT data there is a debate going on whether an adjustment for the baseline value of the outcome variable should be made. When an adjustment is made, there is a lot of misunderstanding regarding the way this should be done. Therefore, the aims of this educational paper are: 1) to…
The purpose of late phase clinical trials is to generate evidence of sufficient validity and generalisability to be translated into practice and policy to improve health outcomes. It is therefore crucial that the chosen endpoints are meaningful to the clinicians, patients and policymakers that are the end-users of evidence generated by these trials. The choice…
BACKGROUND: The demand for clinical trial participants is today one of the highest it has ever been and continues to increase. At the same time, subject recruitment continues to be problematic and the major reason for clinical trial premature terminations. The literature on clinical trial recruitment, which spans several decades and includes hundreds of studies,…
In oncology, next generation sequencing and comprehensive genomic profiling have enabled the detailed classification of tumors using molecular biology. However, it is unrealistic to conduct phase I-III trials according to each sub-population based on patient molecular subtypes. Common protocols that assess the combination of several molecular markers and their targeted therapies by means of multiple…
